FDA — authorised 6 October 2006
- Application: NDA021912
- Marketing authorisation holder: LUPIN
- Local brand name: BROVANA
- Indication: SOLUTION — INHALATION
- Status: approved
🇺🇸 Nebulized arformoterol in United States
FDA authorised Nebulized arformoterol on 6 October 2006
Marketing authorisations
FDA
- Status: approved
Nebulized arformoterol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Nebulized arformoterol approved in United States?
Yes. FDA authorised it on 6 October 2006; FDA has authorised it.
Who is the marketing authorisation holder for Nebulized arformoterol in United States?
LUPIN holds the US marketing authorisation.